In the clinic: Migraine

Annals of Internal Medicine

Volumn 159, Issue 9, 2013, Pages

  MacGregor, E Anne ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALMOTRIPTAN; CAFFEINE; DIHYDROERGOTAMINE; ELETRIPTAN; FROVATRIPTAN; IBUPROFEN; METOCLOPRAMIDE; NAPROXEN; NARATRIPTAN; PARACETAMOL; PROCHLORPERAZINE; PROMETHAZINE; RIZATRIPTAN; SUMATRIPTAN; ZOLMITRIPTAN;

ARTICLE; BEHAVIOR THERAPY; CLINICAL FEATURE; DIET; DIFFERENTIAL DIAGNOSIS; ELECTROENCEPHALOGRAM; FOLLOW UP; GIANT CELL ARTERITIS; HOSPITALIZATION; HUMAN; MIGRAINE; PHYSICAL EXAMINATION; PREGNANCY; PRIORITY JOURNAL; RELAXATION TRAINING; TENSION HEADACHE; MIGRAINE DISORDERS; PATIENT EDUCATION; RISK FACTOR; REVIEW;

DIAGNOSIS, DIFFERENTIAL; HUMANS; MIGRAINE DISORDERS; PATIENT EDUCATION AS TOPIC; RISK FACTORS;

EID: 84887939892     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Michel P, Dartigues JF, Henry P, et al. Validity of the International Headache Society criteria for migraine. GRIM. Groupe de Recherche Interdisciplinaire sur la Migraine. Neuroepidemiology. 1993; 12: 51-7. [PMID: 8327023]
2. Rodriguez-Valverde V, Sarabia JM, Gonzalez- Gay MA, et al. Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica. Am J Med. 1997; 102: 331-6. [PMID: 9217613]
3. Huston KA, Hunder GG, Lie JT, et al. Temporal arteritis: a 25- year epidemiologic, clinical, and pathologic study. Ann Intern Med. 1978; 88: 162-7. [PMID: 626444]
4. Frishberg BM. The utility of neuroimaging in the evaluation of headache in patients with normal neurologic examinations. Neurology. 1994; 44: 1191-7. [PMID: 8035914]
5. Frishberg BM, Rosenberg JH, Matchar DB, et al. Evidence-based guidelines for migraine headache: neuroimaging in patients with nonacute headache. US Headache Consortium; 2000. www.aan.com
6. Gronseth GS, Greenberg MK. The utility of the electroencephalogram in the evaluation of patients presenting with headache: a review of the literature. Neurology. 1995; 45: 1263-7. [PMID: 7617180]
7. Facchinetti F, Allais G, Nappi RE, et al. Migraine is a risk factor for hypertensive disorders in pregnancy: a prospective cohort study. Cephalalgia. 2009; 29: 286-92. [PMID: 19220309]
8. American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 299. Obstet Gynecol. 2004; 104: 647- 51 [PMID: 15339791]
9. Peatfield RC. Relationships between food, wine, and beer-precipitated migrainous headaches. Headache. 1995; 35: 355-7. [PMID: 7635722]
10. Van den Bergh V, Amery WK, Waelkens J. Trigger factors in migraine: a study conducted by the Belgian Migraine Society. Headache. 1987; 27: 191-6. [PMID: 3597073]
11. Egger J, Carter CM, Wilson J, et al. Is migraine food allergy? A double-blind controlled trial of oligoantigenic diet treatment. Lancet. 1983; 2: 865-9. [PMID: 6137694]
12. Mansfield LE, Vaughan TR, Waller SF, et al. Food allergy and adult migraine: double- blind and mediator confirmation of an allergic etiology. Ann Allergy. 1985; 55: 126-9. [PMID: 4025956]
13. Holroyd KA, Penzien DB. Pharmacological versus non-pharmacological prophylaxis of recurrent migraine headache: a meta-analytic review of clinical trials. Pain. 1990; 42: 1-13. [PMID: 2146583]
14. Lipton RB, Baggish JS, Stewart WF, et al. Efficacy and safety of acetaminophen in the treatment of migraine: results of a randomized, doubleblind, placebo-controlled, populationbased study. Arch Intern Med. 2000; 160: 3486-92. [PMID: 11112243]
15. Kirthi V, Derry S, Moore RA, McQuay HJ. Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 2010; 4: CD008041
16. Goldstein J, Hoffman HD, Armellino JJ, et al. Treatment of severe, disabling migraine attacks in an over-the-counter population of migraine sufferers: results from three randomized, placebo-controlled studies of the combination of acetaminophen, aspirin, and caffeine. Cephalalgia. 1999; 19: 684- 91
17. Rabbie R, Derry S, Moore RA, et al. Ibuprofen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2010; (10): CD008039.
18. Tfelt-Hansen P, Henry P, Mulder LJ, Scheldewaert RG, et al. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet. 1995; 346: 923-6. [PMID: 7564725]
19. Friedman BW, Mulvey L, Esses D, et al. Metoclopramide for acute migraine: a dose-finding randomized clinical trial. Annals of emergency medicine. 2011; 57: 475-82. [PMID: 21227540]
20. Lipton RB, Stewart WF, Stone AM, et al. Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) Study: A randomized trial. JAMA. 2000; 284: 2599-605. [PMID: 11086366]
21. Tfelt-Hansen P. Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat. Cephalalgia. 1998; 18: 532-8. [PMID: 9827244]
22. Ferrari MD, Roon KI, Lipton RB, et al. Oral triptans (serotonin 5- HT(1B/1D) agonists) in acute migraine treatment: a metaanalysis of 53 trials. Lancet. 2001; 358: 1668-75. [PMID: 11728541]
23. Oldman AD, Smith LA, McQuay HJ, et al. Pharmacological treatments for acute migraine: quantitative systematic review. Pain. 2002; 97: 247-57. [PMID: 12044621]
24. Gilman PK. Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review. Headache 2010; 50: 264-72. [PMID: 19925619]
25. Winner P, Ricalde O, Le Force B, et al. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine. Arch Neurol. 1996; 53: 180-4. [PMID: 8639069]
26. Colman I, Brown MD, Innes GD, et al. Parenteral dihydroergotamine for acute migraine headache: a systematic review of the literature. Ann Emerg Med. 2005; 45: 393-401. [PMID: 15795718]
27. Tfelt-Hansen P, Saxena PR, Dahlof C, et al. Ergotamine in the acute treatment of migraine: a review and European consensus. Brain. 2000; 123: 9-18. [PMID: 10611116]
28. Colman I, Brown MD, Innes GD, et al. Parenteral metoclopramide for acute migraine: metaanalysis of randomised controlled trials. BMJ. 2004; 329: 1369-73. [PMID: 1555040]
29. Friedman BW, Corbo J, Lipton RB, et al. A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines. Neurology. 2005; 64: 463-8. [PMID: 15699376]
30. Kelly AM, Walcynski T, Gunn B. The relative efficacy of phenothiazines for the treatment of acute migraine: a metaanalysis. Headache. 2009; 49: 1324-32. [PMID: 19496829]
31. Holroyd KA, Cordingley GE, Pingel JD, et al. Enhancing the effectiveness of abortive therapy: a controlled evaluation of self-management training. Headache. 1989; 29: 148-53. [PMID: 2496052]
32. Morey SS. Guidelines on migraine: part 4. General principles of preventive therapy. Am Fam Physician. 2000; 62: 2359-60, 2363. [PMID: 11126860]
33. Silberstein S, Holland S, Freitag F, et al. Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 2012; 78: 1337-4 [PMID: 3335452]) Correction published in Neurology 2013; 80: 871
34. Silberstein SD, Elkind AH, Schreiber C, Keywood C. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology. 2004; 63: 261-9. [PMID: 15277618]
35. Holland S, Silberstein SD, Freitag F, et al. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 2012; 78: 1346-53. [PMID: 3335449]
36. Dodick DW, Turkel CC, DeGryse RE et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo- controlled phases of the PREEMPT clinical program. Headache 2010; 50: 921-936 [PMID: 20487038]
37. Diener HC, Bussone G, Van Oene JC et al. Topiramate reduces headache days in chronic migraine: a randomized, doubleblind, placebo-controlled study. Cephalalgia 2007; 27: 814-823[PMID: 17441971])
38. Granella F, Sances G, Zanferrari C, et al. Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache. 1993; 33: 385-9. [PMID: 8376100]
39. Adeney KL, Williams MA, Miller RS, et al. Risk of preeclampsia in relation to maternal history of migraine headaches. J Matern Fetal Neonatal Med 2005; 18: 167[PMID: 16272039]
40. Scharff L, Marcus DA, Turk DC. Maintenance of effects in the nonmedical treatment of headaches during pregnancy. Headache. 1996; 36: 285-90. [PMID: 8682668]
41. Duong S, Bozzo P, Nordeng H, Einarson A. Safety of triptans for migraine headaches during pregnancy and breastfeeding. Can Fam Physician. 2010; 56: 537-9. [PMID: 20547518]
42. Olesen C, Steffensen FH, Sorensen HT, et al. Pregnancy outcome following prescription for sumatriptan. Headache. 2000; 40: 20-4. [PMID: 10759898]
43. Gallagher RM. Emergency treatment of intractable migraine. Headache.1986; 26: 7 4-5. [PMID: 3957657]
44. Saper JR, Lake AE III, Madden SF, et al. Comprehensive/tertiary care for headache: a 6- month outcome study. Headache. 1999; 39: 249-63. [PMID: 9747046].
45. Facchinetti F, Allais G, Nappi RE, et al. Migraine is a risk factor for hypertensive disorders in pregnancy: a prospective cohort study. Cephalalgia. 2009; 29: 286[PMID: 19220309]
46. Holroyd KA, Cordingley GE, Pingel JD, et al. Enhancing the effectiveness of abortive therapy: a controlled evaluation of self-management training. Headache. 1989; 29: 148-53. [PMID: 2496052]
47. Hoodin F, Brines BJ, Lake AE 3rd, et al. Behavioral self-management in an inpatient headache treatment unit: increasing adherence and relationship to changes in affective distress. Headache. 2000; 40: 377-83. [PMID: 10849032]